Smoking history is associated to cognitive impairment in Parkinson's disease

References

• Alves, G., Kurz, M., Lie, S.A., & Larsen, J.P. (2004). Cigarette smoking in Parkinson's disease: Influence on disease progression. Movement Disorders, 19(9), 1087–1092. doi:10.1002/mds.20117
   PubMed Web of Science ®Google Scholar
• Barone, P., Aarsland, D., Burn, D., Emre, M., Kulisevsky, J., & Weintraub, D. (2011). Cognitive impairment in nondemented Parkinson's disease. Movement Disorders, 26(14), 2483–2495. doi:10.1002/mds.23919
   PubMed Web of Science ®Google Scholar
• Bordia, T., McGregor, M., Papke, R.L., Decker, M.W., McIntosh, J.M., & Quik, M. (2015). The α7 nicotinic receptor agonist ABT-107 protects against nigrostriatal damage in rats with unilateral 6-hydroxydopamine lesions. Experimental Neurology, 263, 277–284. doi:10.1016/j.expneurol.2014.09.015
   PubMed Web of Science ®Google Scholar
• Chang, R.C.-C., Ho, Y.-S., Wong, S., Gentleman, S.M., & Ng, H.-K. (2014). Neuropathology of cigarette smoking. Acta Neuropathologica, 127(1), 53–69. doi:10.1007/s00401-013-1210-x
   PubMed Web of Science ®Google Scholar
• Derkinderen, P., Shannon, K.M., & Brundin, P. (2014). Gut feelings about smoking and coffee in Parkinson's disease. Movement Disorders, 29(8), 976–979. doi:10.1002/mds.25882
   PubMed Web of Science ®Google Scholar
• Doiron, M., & Simard, M. (2012). Idiopathic Parkinson's disease, vascular risk factors and cognition: A critical review. In Dr. L.M. Martins (Ed.), Neurodegeneration. (pp. 323–362). Croatia: InTech. doi:10.5772/34638
   Google Scholar
• Durazzo, T.C., Meyerhoff, D.J., & Nixon, S.J. (2010). Chronic cigarette smoking: Implications for neurocognition and brain neurobiology. International Journal of Environmental Research and Public Health, 7(10), 3760–3791. doi:10.3390/ijerph7103760
   PubMed Web of Science ®Google Scholar
• Folstein, M.F., Folstein, S.E., McHugh, P.R., & Fanjiang, G. (2001). Mini-mental state examination, user's guide. Odessa, FL: Psychological Assessment Resources ( French version: http://www4.parinc.com/Products/Product.aspx?ProductID=MMSE).
   Google Scholar
• Gallagher, D.A., Lees, A.J., & Schrag, A. (2010). What are the most important nonmotor symptoms in patients with Parkinson's disease and are we missing them? Movement Disorders, 25(15), 2493–2500. doi:10.1002/mds.23394
   PubMed Web of Science ®Google Scholar
• Hughes, A.J., Daniel, S.E., Kilford, L., & Lees, A.J. (1992). Accuracy of clinical diagnosis of idiopathic Parkinson's disease: A clinico-pathological study of 100 cases. Journal of Neurology, 55(3), 181–184. doi:10.1136/jnnp.55.3.181
   Web of Science ®Google Scholar
• Hughes, A.J., Daniel, S.E., & Lees, A.J. (2001). Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease. Neurology, 57(8), 1497–1499. doi:10.1212/WNL.57.8.1497
   PubMed Web of Science ®Google Scholar
• Lee, J.E., Park, H.-J., Park, B., Song, S.K., Sohn, Y.H., Lee, J.D., & Lee, P.H. (2010). A comparative analysis of cognitive profiles and white-matter alterations using voxel-based diffusion tensor imaging between patients with Parkinson's disease dementia and dementia with Lewy bodies. Journal of Neurology, Neurosurgery, and Psychiatry, 81(3), 320–326. doi:10.1136/jnnp.2009.184747
   PubMed Web of Science ®Google Scholar
• Levy, G., Tang, M., Cote, L.J., Louis, E.D., Alfaro, B., Mejia, H., … Marder, K. (2002). Do risk factors for Alzheimer's disease predict dementia in Parkinson's disease ? An exploratory study. Movement Disorders, 17(2), 250–257. doi:10.1002/mds.10086
   PubMed Web of Science ®Google Scholar
• Litvan, I., Aarsland, D., Adler, C.H., Goldman, J.G., Kulisevsky, J., Mollenhauer, B., … Weintraub, D. (2011). MDS task force on mild cognitive impairment in Parkinson's disease: Critical review of PD-MCI. Movement Disorders, 26(10), 1814–1824. doi:10.1002/mds.23823
   PubMed Web of Science ®Google Scholar
• Marder, K., Flood, P., Cote, L., & Mayeux, R. (1990). A pilot study of risk factors for dementia in Parkinson's disease. Movement Disorders, 5(2), 156–161. doi:10.1002/mds.870050212
   PubMed Web of Science ®Google Scholar
• Newhouse, P., Kellar, K., Aisen, P., White, H., Wesnes, K., Coderre, E., … Levin, E.D. (2012). Nicotine treatment of mild cognitive impairment: A 6-month double-blind pilot clinical trial. Neurology, 78(2), 91–101. doi:10.1212/WNL.0b013e31823efcbb
   PubMed Web of Science ®Google Scholar
• Pendlebury, S.T., Cuthbertson, F.C., Welch, S.J. V, Mehta, Z., & Rothwell, P.M. (2010). Underestimation of cognitive impairment by Mini-Mental State Examination versus the Montreal Cognitive Assessment in patients with transient ischemic attack and stroke: A population-based study. Stroke, 41(6), 1290–1293. doi:10.1161/STROKEAHA.110.579888
   PubMed Web of Science ®Google Scholar
• Peters, R., Poulter, R., Warner, J., Beckett, N., Burch, L., & Bulpitt, C. (2008). Smoking, dementia and cognitive decline in the elderly, a systematic review. BMC Geriatrics, 8(1), 36. doi:10.1186/1471-2318-8-36
   PubMedGoogle Scholar
• Poletti, M., Frosini, D., Pagni, C., Baldacci, F., Nicoletti, V., Tognoni, G., … Bonuccelli, U. (2012). Mild cognitive impairment and cognitive-motor relationships in newly diagnosed drug-naive patients with Parkinson's disease. Journal of Neurology, Neurosurgery, and Psychiatry, 83(6), 601–606. doi:10.1136/jnnp-2011-301874
   PubMed Web of Science ®Google Scholar
• Quik, M. (2004). Smoking, nicotine and Parkinson's disease. Trends in Neurosciences, 27(9), 561–568. doi:10.1016/j.tins.2004.06.008
   PubMed Web of Science ®Google Scholar
• Rektor, I., Goldemund, D., Sheardová, K., Rektorová, I., Michálková, Z., & Dufek, M. (2009). Vascular pathology in patients with idiopathic Parkinson's disease. Parkinsonism & Related Disorders, 15(1), 24–29. doi:10.1016/j.parkreldis.2008.02.007
   PubMed Web of Science ®Google Scholar
• Riedel, O., Klotsche, J., Spottke, A., Deuschl, G., Förstl, H., Henn, F., … Wittchen, H.-U. (2008). Cognitive impairment in 873 patients with idiopathic Parkinson's disease. Results from the German Study on Epidemiology of Parkinson's Disease with Dementia (GEPAD). Journal of Neurology, 255(2), 255–264. doi:10.1007/s00415-008-0720-2
   PubMed Web of Science ®Google Scholar
• Ritz, B., Ascherio, A., Checkoway, H., Marder, K.S., Nelson, L.M., Rocca, W.A., … Gorell, J. (2007). Pooled analysis of tobacco use and risk of Parkinson disease. Archives of Neurology, 64(7), 990–997. doi:10.1001/archneur.64.7.990
   PubMed Web of Science ®Google Scholar
• Robbins, T.W., & Cools, R. (2014). Cognitive deficits in Parkinson's disease: A cognitive neuroscience perspective. Movement Disorders, 29(5), 597–607. doi:10.1002/mds.25853
   PubMed Web of Science ®Google Scholar
• Sabia, S., Elbaz, A., Dugravot, A., Head, J., Shipley, M., Hagger-Johnson, G., … Singh-Manoux, A. (2012). Impact of smoking on cognitive decline in early old age: The Whitehall II cohort study. Archives of General Psychiatry, 69(6), 627–635. doi:10.1001/archgenpsychiatry.2011.2016
   PubMed Web of Science ®Google Scholar
• Takeuchi, H., Yanagida, T., Inden, M., Takata, K., Kitamura, Y., Yamakawa, K., … Shimohama, S. (2009). Nicotinic receptor stimulation protects nigral dopaminergic neurons in rotenone-induced Parkinson's disease models. Journal of Neuroscience Research, 87(2), 576–585. doi:10.1002/jnr.21869
   PubMed Web of Science ®Google Scholar
• Vossius, C., Larsen, J.P., Janvin, C., & Aarsland, D. (2011). The economic impact of cognitive impairment in Parkinson's disease. Movement Disorders, 26(8), 1541–1544. doi:10.1002/mds.23661
   PubMed Web of Science ®Google Scholar
• Webb, A.J.S., Pendlebury, S.T., Li, L., Simoni, M., Lovett, N., Mehta, Z., & Rothwell, P.M. (2014). Validation of the Montreal cognitive assessment versus mini-mental state examination against hypertension and hypertensive arteriopathy after transient ischemic attack or minor stroke. Stroke, 45(11), 3337–3342. doi:10.1161/STROKEAHA.114.006309
   PubMed Web of Science ®Google Scholar
• Weisskopf, M.G., Grodstein, F., & Ascherio, A. (2007). Smoking and cognitive function in Parkinson's disease. Movement Disorders, 22(5), 660–665. doi:10.1002/mds.21373
   PubMed Web of Science ®Google Scholar